Is the initial acne flare normal?

Yes. An initial flare of acne (often called a 'purge') occurs in the first 1-6 weeks of isotretinoin treatment in many patients as sebum is mobilized. This is expected and does not mean the medication is not working. Your dermatologist may have you start at a lower dose to reduce the severity of the initial flare. The flare typically resolves by weeks 4-8.

What is the iPLEDGE program?

iPLEDGE is a mandatory FDA-required risk management program for isotretinoin due to its extreme teratogenicity. All patients must be registered. Females of reproductive potential must use two forms of contraception simultaneously, have monthly pregnancy tests, and answer monthly iPLEDGE questionnaires to obtain their prescription. Males must also complete the program. This system exists because isotretinoin causes severe birth defects in virtually all exposed pregnancies.

Will my acne come back after isotretinoin?

About 85% of patients who complete a full course achieve permanent or near-permanent remission. Of those who have some recurrence, many do not require retreatment or respond to topical treatments. A second course of isotretinoin can be done if needed.

Can I take vitamin A supplements while on isotretinoin?

No. Isotretinoin is a vitamin A derivative. Taking additional vitamin A or high-dose multivitamins containing vitamin A while on isotretinoin causes vitamin A toxicity — headaches, vision changes, liver damage. Avoid all vitamin A supplements during treatment. Standard dietary vitamin A from food is fine.

What to Expect When Starting Isotretinoin

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Isotretinoin (formerly Accutane, now available as Absorica, Claravis, and others) is an oral retinoid used to treat severe, treatment-resistant cystic or nodular acne. It is the only medication that can permanently reduce acne by shrinking sebaceous glands, normalizing skin cell shedding, and reducing bacteria. The treatment course is 4-6 months, with most patients achieving long-term remission. Due to severe teratogenicity, it is dispensed only through the iPLEDGE risk management program.

Week-by-week timeline

Week 1-2

Enrollment, Labs, and First Dose

Before starting, you must be enrolled in iPLEDGE, have two negative pregnancy tests (if female), and have baseline labs (lipids, liver enzymes). Isotretinoin is taken twice daily with food (a fatty meal significantly increases absorption by up to 50%). Starting dose is typically 0.5-1 mg/kg/day. Dryness begins immediately — lip balm is essential from day one.

Week 2-6

Initial Acne Flare and Maximum Dryness

Many patients experience an initial flare of acne in the first 1-6 weeks as the drug mobilizes sebum from clogged pores. This is expected and does not mean the treatment is failing. Skin and lip dryness peak in the first 1-2 months. Moisturizer and lip balm are essential. Avoid waxing, laser, and dermabrasion during treatment.

Month 1-3

Skin Improvement Beginning

After the initial flare settles (usually by month 1-2), acne begins to clear progressively. Monthly labs are required. Monthly pregnancy tests and the 30-day prescription window mean monthly prescriber visits or coordination. Skin sensitivity to sun increases dramatically — use SPF 30+ daily.

Month 3-4

Significant Clearance

Most patients notice substantial acne clearance by months 3-4. Dryness of skin, lips, and eyes (contact lens users may have difficulty) is at its peak. Nosebleeds from dry mucous membranes are common — use nasal saline.

Month 4-6

Completing the Course

Completing the full cumulative dose (typically 120-150 mg/kg total over the course) is critical for long-term remission. Most patients clear completely by the end of the course. Post-treatment, the full benefit continues for months as sebaceous glands remain suppressed.

When to call your doctor

Contact your healthcare provider if you experience:

Severe or worsening depression, mood changes, or thoughts of self-harm (isotretinoin carries FDA warnings regarding psychiatric effects — monitor closely)
Any possibility of pregnancy — isotretinoin causes catastrophic birth defects (iPLEDGE program mandatory for all females of childbearing potential)
Severe abdominal pain or bloody diarrhea (rare inflammatory bowel disease association)
Severe headache with nausea and visual disturbances (possible pseudotumor cerebri/intracranial hypertension)
Blurred vision, difficulty seeing at night (night vision impairment)
Severe joint or muscle pain
Hearing changes or ringing in ears
Severe allergic reaction: rash, facial swelling, difficulty breathing

Tips for getting started

Use a rich, fragrance-free moisturizer on your face, body, and lips every day — twice daily is better. Carry lip balm everywhere. Avoid harsh skincare products (exfoliants, Retinoids, alcohol-based toners) during treatment. Always apply SPF 30+ sunscreen — sun sensitivity is dramatically increased. Take each dose with a high-fat meal to ensure maximum drug absorption. Never share isotretinoin — it is dangerous to others, especially those who could become pregnant. Do not donate blood during treatment and for 30 days after. If female, use two forms of contraception simultaneously throughout treatment and for one month after the last dose.

Frequently asked questions

More about Isotretinoin

Isotretinoin drug guideSide effects, dosage, interactions, and more Doxycycline vs IsotretinoinCompare these medications Isotretinoin & DoxycyclineInteraction details

References

[Regulatory] FDA Label: Absorica (isotretinoin) Capsules https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202055lbl.pdf Accessed 2026-03-01.
[Regulatory] NIH MedlinePlus: Isotretinoin https://medlineplus.gov/druginfo/meds/a681043.html Accessed 2026-03-01.
[Regulatory] FDA iPLEDGE Program Information https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/isotretinoin-ipledge Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: March 1, 2026